Menstrual Irregularity Clinical Trial
Official title:
Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers: A Focus on the Apoptosis Marker M30, the Endothelial Function Marker Asymmetric Dimethylarginine and Malondialdehyde
A cross-sectional study design was employed, involving 56 premenopausal participants with ages ranging from 20 to 49 years. Serum samples were collected during the early follicular phase, and levels of some biochemicals parameters analyzed.
A cross-sectional study was conducted to investigate the potential relationship between menstrual regularity and the apoptosis marker caspase-cleaved cytokeratin 18 fragment (M30), Asymmetric dimethylarginine (ADMA), and Malondialdehyde (MDA) levels. The investigators screened 80 participants who applied for menstrual irregularity between 2023 February and 2024 March and, in addition to menstrual irregularities, 24 individuals with additional gynecological conditions such as polycystic ovary syndrome (PCOS) and endometriosis were excluded from the study. In the overall study population of 56 subjects aged 20-49 were recruited from, Sivas Cumhuriyet University Faculty of Medicine Research and Practice Hospital, Gynecology and Obstetrics Clinic. Participants were divided into two groups: irregular menstrual cycle (28 participants) and regular menstrual cycle control group (28 participants). While those who met the criteria for menstrual irregularity were included, those with another gynecological disease (PCOS, endometriosis, etc.) and additional diseases (diabetes, insulin resistance, cancer, heart disease, etc.) were excluded from the study. All participants provided written informed consent before participating in the study. The study protocol was approved by the Sivas Cumhuriyet University, Clinical Research Ethics Committee Chairman, 2023-02/06. All procedures were performed in accordance with the ethical standards laid down in the Declaration of Helsinki. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05688995 -
COVID-19 Vaccines and the Menstrual Cycle
|
||
| Completed |
NCT01927471 -
Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
|
||
| Completed |
NCT00392873 -
Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity
|
N/A | |
| Completed |
NCT05083065 -
Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
|
||
| Recruiting |
NCT04940013 -
Missed Period Pill Study
|
Phase 4 | |
| Completed |
NCT03547453 -
Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
|
||
| Completed |
NCT04985591 -
The Effect of Liposuction on Menses: a Retrospective Study
|
Early Phase 1 | |
| Completed |
NCT04006171 -
Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women
|
N/A | |
| Completed |
NCT01555190 -
Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone
|
N/A | |
| Active, not recruiting |
NCT05230316 -
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
|
||
| Completed |
NCT05410314 -
Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma
|
||
| Withdrawn |
NCT05518006 -
An Investigation of Premama Balance and Its Effects on Hormonal Imbalances
|
N/A | |
| Not yet recruiting |
NCT05224726 -
Platelet Rich Plasma for Uterine Scar
|
N/A | |
| Completed |
NCT04413058 -
Menstrual Cycle Characteristics of Healthcare Professionals
|
||
| Recruiting |
NCT05197491 -
Women's Menstruation During the Covid-19 Pandemic
|